1. Home
  2. CABA vs FTRK Comparison

CABA vs FTRK Comparison

Compare CABA & FTRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • FTRK
  • Stock Information
  • Founded
  • CABA 2017
  • FTRK 2012
  • Country
  • CABA United States
  • FTRK Singapore
  • Employees
  • CABA N/A
  • FTRK N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • FTRK
  • Sector
  • CABA Health Care
  • FTRK
  • Exchange
  • CABA Nasdaq
  • FTRK NYSE
  • Market Cap
  • CABA 118.8M
  • FTRK 102.2M
  • IPO Year
  • CABA 2019
  • FTRK 2025
  • Fundamental
  • Price
  • CABA $1.79
  • FTRK $5.95
  • Analyst Decision
  • CABA Strong Buy
  • FTRK
  • Analyst Count
  • CABA 8
  • FTRK 0
  • Target Price
  • CABA $18.88
  • FTRK N/A
  • AVG Volume (30 Days)
  • CABA 2.5M
  • FTRK 1.9M
  • Earning Date
  • CABA 08-07-2025
  • FTRK 01-01-0001
  • Dividend Yield
  • CABA N/A
  • FTRK N/A
  • EPS Growth
  • CABA N/A
  • FTRK N/A
  • EPS
  • CABA N/A
  • FTRK N/A
  • Revenue
  • CABA N/A
  • FTRK $117,230.00
  • Revenue This Year
  • CABA N/A
  • FTRK N/A
  • Revenue Next Year
  • CABA N/A
  • FTRK N/A
  • P/E Ratio
  • CABA N/A
  • FTRK N/A
  • Revenue Growth
  • CABA N/A
  • FTRK 2589.48
  • 52 Week Low
  • CABA $0.99
  • FTRK $3.15
  • 52 Week High
  • CABA $9.25
  • FTRK $9.69
  • Technical
  • Relative Strength Index (RSI)
  • CABA 47.69
  • FTRK N/A
  • Support Level
  • CABA $1.56
  • FTRK N/A
  • Resistance Level
  • CABA $2.02
  • FTRK N/A
  • Average True Range (ATR)
  • CABA 0.24
  • FTRK 0.00
  • MACD
  • CABA -0.06
  • FTRK 0.00
  • Stochastic Oscillator
  • CABA 22.33
  • FTRK 0.00

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

About FTRK FAST TRACK GROUP

Fast Track Group is a regional entertainment-focused event management and marketing company that provides a full range of services including experiential marketing, artiste endorsement and management, movie premiere organizations, grand openings, and concerts. It also creates, develops, organizes, hosts, and manages various events and concerts.

Share on Social Networks: